Nucleotide phosphoramidates as anticancer agents

Details for Australian Patent Application No. 2004261455 (hide)

Owner Cardiff Protides Limited

Inventors McGuigan, Christopher

Agent Davies Collison Cave

Pub. Number AU-B-2004261455

PCT Pub. Number WO2005/012327

Priority 0317009.9 21.07.03 GB

Filing date 20 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 23 December 2010

International Classifications

C07H 19/10 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2005/012327 Priority application(s): WO2005/012327

9 October 2008 Assignment before Grant

  University College Cardiff Consultants Limited The application has been assigned to Cardiff Protides Limited

23 December 2010 Application Accepted

  Published as AU-B-2004261455

21 April 2011 Standard Patent Sealed

30 June 2011 Licence Registered

  Cardiff Protides Limited ( NuCana BioMed Limited )

5 July 2012 Assignment Registered

  Cardiff Protides Limited The patent has been assigned to Nucana Biomed Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004261459-3, 4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators

2004261453-Synthetic method for the preparation of quinazolin-4-one derivative